Rankings
▼
Calendar
BBIO Q4 2018 Earnings — BridgeBio Pharma, Inc. Revenue & Financial Results | Market Cap Arena
BBIO
BridgeBio Pharma, Inc.
$14B
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$66M
Net Income
-$39M
EPS (Diluted)
$-0.42
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$46M
Free Cash Flow
-$47M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$465M
Total Liabilities
$566M
Stockholders' Equity
-$164M
Cash & Equivalents
$436M
← FY 2018
All Quarters
Q1 2019 →